Summary Box: FDA panel vote on HIV prevention drug

By: Associated Press Email
By: Associated Press Email

The Food and Drug Administration holds a meeting Thursday to decide whether a daily pill called Truvada should be approved for people who are at risk of contracting HIV. A positive review posted Tuesday suggests the pill will become the first drug approved to prevent HIV infection in healthy patients.

Thursday's discussion is likely to focus on which patients should take the drug. The FDA will ask a panel of outside experts to vote on whether Truvada should be approved for:

- gay and bisexual men
- men or women in relationships with HIV-positive partners
- other people at risk of acquiring HIV through sexual activity

The FDA is not required to follow the advice of its panels, though it usually does. A final decision on the drug is expected by June 15.


Comments are posted from viewers like you and do not always reflect the views of this station.
powered by Disqus
WNDU - Channel 16 54516 State Road 933 South Bend, IN 46637 Front Desk: 574-284-3000 Newsroom: 574-284-3016 Email: newscenter16@wndu.com
Copyright © 2002-2014 - Designed by Gray Digital Media - Powered by Clickability 150996645 - wndu.com/a?a=150996645
Gray Television, Inc.